The patient is scheduled to undergo a second surgery aiming for an extent of resection greater than 90%, as it has been discussed that the extent of resection could have a significant prognostic impact on astrocytoma, IDH-mutant, CNS WHO grade 3 (Figure 2) [10]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).